<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02862860</url>
  </required_header>
  <id_info>
    <org_study_id>Duvillard Hors AOI 2011</org_study_id>
    <nct_id>NCT02862860</nct_id>
  </id_info>
  <brief_title>Search for a Link Between the Different Variables for Glycaemia and Oxidative Stress or Impaired HDL Function</brief_title>
  <acronym>Holter Gly</acronym>
  <official_title>Influence of Glycaemic Variability on Oxidative Stress and High-density Lipoprotein (HDL) Function in Type-1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      As glycaemic variability on the one hand and hypoglycaemia on the other are associated with
      oxidative stress and inflammation, they are likely, in type-1 diabetic patients, to affect
      the oxidation of lipoproteins and HDL function, by altering their anti-atherogenic
      properties.

      The aim of this study is thus to determine, in patients with Type 1 Diabetic (T1D) who will
      wear a glycaemic Holter for 1 week, the glycaemia parameters (mean glycaemia, duration of
      hypoglycaemia, duration of hyperglycaemia, mean amplitude of glycaemic excursions) associated
      with proatherogenic alterations in lipoproteins, in particular:

        -  LDL oxidation

        -  HDL oxidation and alterations of HDL function (anti-inflammatory capacity, antioxidant
           capacity)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2012</start_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average blood glucose</measure>
    <time_frame>through study completion, an average of 7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time hypoglycemia</measure>
    <time_frame>through study completion, an average of 7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time hyperglycemia</measure>
    <time_frame>through study completion, an average of 7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Amplitude of glycemic variations</measure>
    <time_frame>through study completion, an average of 7 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Type-1 Diabetes</condition>
  <arm_group>
    <arm_group_label>patients with type-1 diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <arm_group_label>patients with type-1 diabetes</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>urine sample</intervention_name>
    <arm_group_label>patients with type-1 diabetes</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>installation of Holter</intervention_name>
    <arm_group_label>patients with type-1 diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have provided written consent

          -  Patients with national health insurance cover

        Patients with T1D

          -  T1D Patients treated with insulin via a pump or multiple injections

          -  HbA1c &lt; 9.5 %

        Control patients

          -  Normal fasting glycaemia (&lt; 6.1 mmol/L)

          -  Age &gt; 18 years, matched for sex and age with T1D patients

        All patients

          -  Normal serum HDL cholesterol (&gt; 1.04 mmol/L in men, &gt; 1.30 mmol:L in women)

          -  Serum LDL cholesterol &lt; 5 mmol/L

          -  triglyceridemia &lt; 1.7 mmol/L

          -  Waist circumference &lt; 102 cm in men, &lt; 88 cm in women

        Exclusion Criteria:

          -  Smoking

          -  Kidney failure (Creatinine clearance&lt; 60 ml/min/1.73 m2)

          -  Liver failure

          -  Dysthyroidism

          -  Medication that interferes with lipoprotein metabolism (lipid-lowering agents,
             oestroprogestative, anti-HIV, corticoids, retinoic acid), unless stopped for at least
             one 1 month

          -  Antioxidant (vitamin E, dietary supplements, DHA)

          -  Pregnancy of more than 15d
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laurence DUVILLARD</last_name>
    <phone>3.80.29.36. 46</phone>
    <phone_ext>+33</phone_ext>
    <email>laurence.duvillard@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence DUVILLARD</last_name>
      <phone>3.80.29.36. 46</phone>
      <phone_ext>+33</phone_ext>
      <email>laurence.duvillard@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2016</study_first_submitted>
  <study_first_submitted_qc>August 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2016</study_first_posted>
  <last_update_submitted>August 10, 2016</last_update_submitted>
  <last_update_submitted_qc>August 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

